Traduction de «the authorities should develop » (Néerlandais → Français) :

This is the reason why our general recommendation is that the authorities should develop a large-scale and coherent care programme regarding the issue of depression and suicide.
C’est pourquoi, notre recommandation globale est que les autorités développent un large programme de soins cohérent autour de la problématique de la dépression et du suicide.

This release contains forward-looking information about an agreement by Pfizer to acquire FoldRx, and about FoldRx’s product candidate tafamidis, its other clinical and preclinical development programs and its technology platform, including their potential benefits, that involves substantial risks and uncertainties. Such risks and uncertainties include, among other things, the satisfaction of conditions to closing the agreement; the uncertainties inherent in research and development; whether and when a new drug application for tafamidis will be filed with the FDA; decisions by regulatory authorities regarding whether and when to approve any drug applications that have been or may be filed for tafamidis and that may be filed for any other product candidates that may be generated by FoldRx’s technology platform as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of tafamidis and such other product candidates; and competitive developments. A further description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009 and in its reports on Form 10-Q and Form 8-K.
Such risks and uncertainties include, among other things, the satisfaction of conditions to closing the agreement; the uncertainties inherent in research and development; whether and when a new drug application for tafamidis will be filed with the FDA; decisions by regulatory authorities regarding whether and when to approve any drug applications that have been or may be filed for tafamidis and that may be filed for any other product candidates that may be generated by FoldRx’s technology platform as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of tafamidis and such other product candidates; and competitive developments.

Such risks and uncertainties include, among other things, the uncertainties inherent in research and development; whether and when regulatory authorities in countries where regulatory applications for Prevenar 13 may be pending or may be submitted will approve such applications and their decisions regarding labeling and other matters that could affect its availability or commercial potential; and competitive developments.
This release contains forward-looking information that involves substantial risks and uncertainties regarding Prevenar 13, including its potential benefits; and the success of the AMC project for vaccines. Such risks and uncertainties include, among other things, the uncertainties inherent in research and development; whether and when regulatory authorities in countries where regulatory applications for Prevenar 13 may be pending or may be submitted will approve such applications and their decisions regarding labeling and other matters that could affect its availability or commercial potential; and competitive developments. A further description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009, and in its reports on Form 10-Q and Form 8-K.

Indeed, though it is not advisable that there should be a total lack of response on the part of the school authorities and the pedagogical team in cases of suicide, the initiatives taken by “wellmeaning” teachers sometimes have perverse results.
Ainsi si l’absence totale de réaction de la part de la direction et de l’équipe éducative n’est pas conseillée en cas de suicide, les initiatives de professeurs « de bonne volonté » ont parfois des effets pervers.

They should also settle on the agreements that can be made in that region about the providing care to and referring of patients as well as the handling of recurrences. In order to achieve this aim, the authorities may consider providing support to local programmes, following-up on regional data and co-ordinating local health professionals.
Pour y parvenir, les autorités peuvent envisager le soutien de programmes locaux, le suivi des données régionales et la coordination des professionnels de la santé locaux.

The different projects that have been developed are either based on private initiatives or organised and subsidised on a local level (local authorities, province…).
Les différents projets développés le sont soit sur base d’initiatives privées, soit subsidiées et mises en place à un niveau local (communes, province…).

Recognition by the relevant parties at national level and by the other competent authorities at European level for early phase development has without a doubt been a significant achievement for the R&D department and the FAMHP.
Recognition by the relevant parties at national level and by the other competent authorities at European level for early phase development has without a doubt been a significant achievement for the R&D department and the FAMHP.

It is clear that schools too should be more active in playing a complete educational role that takes care that the students show a healthy social and emotional development (cf. the WHO’s “Life Skills” educational curriculum).
Il est évident aussi que les écoles doivent avoir plus activement un rôle éducatif complet favorisant le développement social et affectif sain des élèves (cf. programme d’enseignement de connaissances OMS).

The Resident Assessment Instrument (RAI) 444 is originally developed to Only for breast cancer and colon cancer, the US has higher survival rates assess the care needs of the elderly in institutions, and has later been than Belgium (data shown in documentation sheet in Supplement S1). To extended with instruments for different care settings and subgroups. In be able to distinguish the effect of early screening from the actual care, Belgium a national pilot project (the BelRAI) is ongoing, but is not yet implemented in all care settings: the assessment instruments for home care, relative survival rates should be compared across countries by stage, for long-term care facilities and acute care have already been adapted to information which is not yet available at international level. the Belgian situation (details in Appendix C).
Belgium a national pilot project (the BelRAI) is ongoing, but is not yet be able to distinguish the effect of early screening from the actual care, implemented in all care settings: the assessment instruments for home care, relative survival rates should be compared across countries by stage, for long-term care facilities and acute care have already been adapted to information which is not yet available at international level. the Belgian situation (details in Appendix C).